Lisata Therapeutics
Price & Volume
Stats
See more52W Range | $1.81-$4.20 |
Market Cap | $16.9M |
Shares Short | 15,440 |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $1M |
Diluted EPS | -$2.13 |
News
See moreYahoo Finance • 3 months ago
Lisata Therapeutics Partners with Catalent on ADC Technology
Yahoo Finance • 5 months ago
Lisata extends cash runway into Q4 2026 while advancing certepetide development milestones
Yahoo Finance • 6 months ago
Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update
Yahoo Finance • 6 months ago
Lisata Therapeutics stock price target raised to $32 from $20 at Brookline
About
CEO | Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. |
Address | 110 Allen Road, Basking Ridge, NJ, United States, 07920 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 26 |
